Enovis Corporation
Health
Performance
6.2
Risk
Sell
Buy
Curious about the Scores? Learn more.

Enovis Corporation stock rating and score history

All changes in ratings, performance and outlook tracked over time.

17.07.2026
Tiny rebound. Signs of life appear after deep struggle.
05.06.2026
Off life support. Still risky, but slightly less scary.
24.05.2026
Pulse detected. Still fragile, but stabilizing.
ENOV
Enovis Corporation
27.10
+0.97%
6.2
Sell
Buy
Enovis Corporation

Enovis Corporation stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Enovis Corporation do? Business model and key facts

Get the full picture of Enovis Corporation: what it builds, where it operates, and how it makes money.

Enovis Corporation Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 7802

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.

shop
Company facts
Damien McDonald
CEO
7802
Employees worldwide
shop
Performance
3.04%
Last 12 months
-65.54%
Last 5 years
shop
Growth
$2.25B
Revenue year
$-1,183,620,000
Net income
shop
Valuation
$1.56B
Market Cap
-1.28
Price/Earnings Ratio

Stocks related to Enovis Corporation

Selected based on industry alignment and relative market positioning.

NVCR
Novocure Ltd
16.00
+0.38%
8.0
Sell
Buy
Novocure Ltd
UFPT
UFP Technologies, Inc.
243.94
-0.68%
5.9
Sell
Buy
UFP Technologies, Inc.
AXGN
AxoGen, Inc.
40.26
+1.98%
5.9
Sell
Buy
AxoGen, Inc.
IART
Integra LifeSciences Holdings Corporation
19.01
+0.64%
7.4
Sell
Buy
Integra LifeSciences Holdings Corporation
AHCO
AdaptHealth Corp.
11.21
+2.09%
7.2
Sell
Buy
AdaptHealth Corp.

Events and news impacting Enovis Corporation stock

Earnings, coporate decisions and industry developments that can affect the share price.

Enovis Corporation fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.